Maxime Tremblay-Gravel

Dr. Maxime Tremblay-Gravel

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2008 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
HBHélène Blons
Hélène Blons
KPKarine Pallier
Karine Pallier
DCDelphine Le Corre
Delphine Le Corre
CDClaire Danel
Claire Danel
MTMaxime Tremblay-Gravel
Maxime Tremblay-Gravel
PLPierre Laurent-Puig
Pierre Laurent-Puig
Lung cancer with EGFR mutation was shown to be a specific clinical entity. In order to better understand the biology behind this disease we used a genome wide characterization of loss of heterozygosity and amplification by Single Nucleotide Polymorphism (SNP) Array analysis to point out chromosome segments linked to EGFR mutations. To do so, we compared genetic profiles between EGFR mutated adenocarcinomas (ADC) and KRAS mutated ADC from 24 women with localized lung cancer.

1 February 2023 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Closed access
PDF file
MTMaxime Tremblay-Gravel
Maxime Tremblay-Gravel
KIKenzo Ichimura
Kenzo Ichimura
KPKermshlise Picard
Kermshlise Picard
YKYumeko Kawano
Yumeko Kawano
ADAnnika M. Dries
Annika M. Dries
VPVictoria N Parikh
Victoria N Parikh
Background: In Lamin A/C ( LMNA ) cardiomyopathy, atrial fibrillation (AF) commonly occurs before dilated cardiomyopathy, and the ability to predict its incidence is limited. We hypothesized that left atrial (LA) echocardiographic phenotyping can identify atrial myopathy and harbingers of AF. Methods: Echocardiograms from patients with pathogenic or likely pathogenic variants in LMNA (n=77) with and without reduced left ventricular ejection fraction (LVEF, <50%) were compared to healthy individuals (n=70) and patients with Titin truncating variant cardiomyopathy (TTNtv ) (n=35) with similar LVEF, sex, and age distributions. Echocardiographic analysis, blinded to genotype, included strain and volumetric measures of left ventricular and atrial function. The primary outcome was incident AF. Results: At baseline, 43% of the patients with pathogenic or likely pathogenic LMNA variants had a history of AF, including 26% of those with LVEF ≥50%. Compared with healthy subjects, the patients with pathogenic or likely pathogenic LMNA variants and LVEF ≥50% had reduced LA contractile strain ( LMNA , 11.8±6.1% versus control, 15.0±4.2%; P =0.003). Compared to LVEF-matched ( TTNtv ) patients, the patients with pathogenic or likely pathogenic LMNA variants and LVEF <50% displayed no difference in LA size, but a worse LA contractile dysfunction (6.4±4.7% versus 12.6±9.6%; P =0.02). Over a median follow-up of 2.8 (1.2–5.7) years, LA contractile strain was the only significant predictor of AF in multivariable Cox regression (hazard ratio, 4.0 [95% CI, 1.04–15.2]). Conclusions: LMNA cardiomyopathy is associated with early intrinsic atrial myopathy reflected by high AF prevalence and reduced LA contractile strain, even in the absence of LV dysfunction and LA dilation. Whether LA strain can be used as a monitoring strategy to detect and mitigate AF complications requires validation.

1 April 2020 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
EHErik J. Henricksen
Erik J. Henricksen
MTMaxime Tremblay-Gravel
Maxime Tremblay-Gravel
YMYasbanoo Moayedi
Yasbanoo Moayedi
WYWenjia Yang
Wenjia Yang
RLRoy Lee
Roy Lee
KKKiran K. Khush
Kiran K. Khush

1 August 2019 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
YMYasbanoo Moayedi
Yasbanoo Moayedi
CFChun-Po S. Fan
Chun-Po S. Fan
RMRobert Miller
Robert Miller
MTMaxime Tremblay-Gravel
Maxime Tremblay-Gravel
JPJuan G. Duero Posada
Juan G. Duero Posada
JTJeffrey J. Teuteberg
Jeffrey J. Teuteberg

6 March 2025 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
JGJ. Guzman-Bofarull
J. Guzman-Bofarull
EREduard Ródenas-Alesina
Eduard Ródenas-Alesina
YMY. Moayedi
Y. Moayedi
LTL. Truby
L. Truby
MRM. Rivas-Lasarte
M. Rivas-Lasarte
MFMarta Farrero-Torres
Marta Farrero-Torres

1 July 2018 in International Journal of Cardiology
Verified
Journal Article
Closed access
RARobert Avram
Robert Avram
GMGuillaume Marquis-Gravel
Guillaume Marquis-Gravel
FSFrançois Simard
François Simard
CPChristine Pacheco
Christine Pacheco
ÉCÉtienne Couture
Étienne Couture
EJE. Marc Jolicoeur
E. Marc Jolicoeur